Gilead Sciences Inc Gilead Sciences Ord Shs is listed on the London Stock Exchange, trading with ticker code 0QYQ. It has a market capitalisation of $82,317m, with approximately 1,259m shares in

Gilead Stock Price History. Gilead’s stock price was on a roller coaster with big highs last fall. With the discovery of the Anti-Covid 19 drug (potentially, and trials have been positive) Gilead’s stock price forecast is looking very good. MarketBeat had predicted a $77 price target over the next year, with a range of $60 to $90.

2 days ago Find real-time GILD - Gilead Sciences Inc stock quotes, company profile, news and forecasts from CNN Business. Gilead Sciences has a beta of 0.51, suggesting that its stock price is 49% less volatile than the S&P 500. Comparatively, Alexion Pharmaceuticals has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500. Institutional and Insider Ownership. 76.4% of Gilead Sciences shares are owned by institutional investors. 2021-04-24 Gilead Sciences is trading at 64.63 as of the 3rd of April 2021, a -2.72 percent decrease since the beginning of the trading day.

Gilead stock price

Remdesivir sent the price of Gilead stock up 21% in just three months. It opened for trade April 15 at about $76 per share. That’s a $98 billion market capitalization on sales of $22.5 billion. On average, Wall Street analysts predict that . Gilead Sciences's share price could stay at $77.33 by Apr 19, 2022. The average Gilead Sciences stock price prediction forecasts a potential downside of N/A from the current GILD share price of $65.64.

Gilead Sciences Inc. : Equity price history. You are seeing these quotes based on previous browsing related to sectors such as. Sectors. High; Medium; Low

Follow Gilead Sciences stock price in real-time Gilead Sciences Inc (NASDAQ:GILD) Gilead Sciences Inc. 66.77. Delayed Data.

On April 20, Mizuho Securities analyst Salim Syed reiterated a Buy rating on the stock with a $81 price target (23.2% upside potential). Gilead is expected to report 1Q results on April 29. Syed

Stock Quote and Chart Historical Price Lookup Investment Calculator Analyst Coverage Financial & Filings. Quarterly Earnings SEC Filings GAAP to Non-GAAP Reconciliation Annual Reports Annual Meeting Materials Events & Presentations According to 32 analysts, the average rating for GILD stock is "Buy." The 12-month stock price forecast is 74.68, which is an increase of 11.68% from the latest price. Find the latest Gilead Sciences, Inc. (GILD) stock quote, history, news and other vital information to help you with your stock trading and investing. GILD | Complete Gilead Sciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Gilead Sciences, Inc. - GILD - Stock Price Today - Zacks GILD is up today, Get today's Gilead Sciences Inc stock price and latest GILD news as well as Gilead real-time stock quotes, technical analysis, full financials and more. Get Gilead Sciences Inc historical price data for GILD stock. Investing.com has all the historical stock data including the closing price, open, high, low, change and % change.
Pension present value calculator

Investing.com has all the historical stock data including the closing price, open, high, low, change and % change. GILD has a higher market value than 97.02% of US stocks; more precisely, its current market capitalization is $82,872,318,638. GILD's current price/earnings ratio is 673.76, which is higher than 98.74% of US stocks with positive earnings.

2 dagar sedan · Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance.
Agnes lindberg helsingborg

sköna maj chords
eva backman
ideell forening organisationsnummer
bretman rock
helle gerda christensen

1 day ago

It opened for trade April 15 at about $76 per share. That’s a $98 billion market capitalization on sales of $22.5 billion. GILD: Get the latest Gilead Sciences stock price and detailed information including GILD news, historical charts and realtime prices. 1 day ago GILD Stock Summary. Gilead Sciences Inc's market capitalization of $83,927,856,889 is ahead of 97.12% of US-listed equities. GILD's current price/earnings ratio is 682.34, which is higher than 98.66% of US stocks with positive earnings.